1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2014 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape


The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for HIV-1/2, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:


  - Hospitals 
- Public Health Labs
 - Commercial/Private Labs

  - Blood Banks
  - Physician Offices
  - Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.



Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Table Of Contents

2014 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
I. Introduction
II. AEROMONADS Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Test Volume and Diagnostics Sales Forecast
by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast
by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast
by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast
by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast
by Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecast
by Market Segment
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

List of Tables

France
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.